Disopyramide

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C21H29N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) GFO928U8MQ, chemically known as 2-pyridineacetamide, alpha-(2-(diisopropylamino)ethyl)-alpha-phenyl- but more generally known as disopyramide, which bears US NIH Compound Identifier 3114. European Medicines Agency schedules Disopyramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07237MIG. The term DISOPYRAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). World Health Organization schedules disopyramide in its Anatomical Therapeutic Chemical (ATC) Classification. DISOPYRAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule disopyramide under HS 29333999 and SITC 51574. As of Q4 2014, DISOPYRAMIDE remains US FDA's Preferred Term for this commodity. Disopyramide bears US NLM identifiers UMLS ID C0012702 and NCI Concept Code C61730. SMILES: O=C(N)C(CCN(C(C)C)C(C)C)(C1CCCCC1)C1NCCCC1.